Lv63
2710 积分 2023-11-10 加入
IL1RAP antibody-drug conjugates potently target primary and metastatic disease in multiple oncofusion-driven cancers
10天前
已完结
The BAFF/APRIL system in SLE pathogenesis
1个月前
已完结
Advances in the treatment of systemic lupus erythematosus
1个月前
已完结
The immunology of vitiligo
2个月前
已完结
POS0114 A PLACEBO-CONTROLLED PHASE 1 STUDY IN HEALTHY ADULT VOLUNTEERS OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALPN-303, A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
3个月前
已关闭
POS0114 A PLACEBO-CONTROLLED PHASE 1 STUDY IN HEALTHY ADULT VOLUNTEERS OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ALPN-303, A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
3个月前
已关闭
Membranous nephropathy
4个月前
已完结
Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome Treatment Resistance
4个月前
已完结
Pancreatic cancer
4个月前
已完结
Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies
4个月前
已完结
皖公网安备34019202002308
